![]() “PNI has advanced a number of exciting innovations and we’re thrilled to welcome this talented team,” says Emmanuel Ligner, Danaher Group Executive. PNI will join Danaher’s Life Sciences platform and will be complementary to other businesses in the platform, including Cytiva and Pall. PNI is a global leader in technologies and solutions for the development of genetic medicines, including mRNA vaccines and therapeutics. JPrecision NanoSystems (PNI) has been acquired by Danaher Corporation’s Life Sciences platform. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |